$Expression of COX-1, COX-2, 5-LOX and $$\hbox {CysLT}_2$$ CysLT2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease$

Expression of COX-1, COX-2, 5-LOX and $$\hbox {CysLT}_2$$ CysLT2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease

Abstract Background Aspirin exacerbated respiratory disease (AERD) is a disease of the upper and lower airways. It is characterized by severe asthma, chronic sinusitis with nasal polyps (CRSwNP) and intolerance towards nonsteroidal analgesics (NSAR). Arachidonic acid (AA) metabolites play an importa...

Full description

Bibliographic Details
Main Authors:	Monique Vorsprach, Christoph Arens, Stephan Knipping, Dörte Jechorek, Sabine Stegemann-Koniszewski, Eva Lücke, Jens Schreiber
Format:	Article
Language:	English
Published:	BMC 2019-12-01
Series:	Allergy, Asthma & Clinical Immunology
Subjects:	Asthma Nasal polyps Aspirin exacerbated respiratory disease Arachidonic acid Cyclooxygenases Lipoxygenases
Online Access:	https://doi.org/10.1186/s13223-019-0395-5

Similar Items

Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction
by: Tomohiko Sekioka, et al.
Published: (2015-10-01)

A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes
by: Valérie Capra, et al.
Published: (2010-05-01)

CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
by: Sayeh Savari, et al.
Published: (2013-01-01)

CysLT2 receptor antagonist HAMI3379 inhibits LPS-induced inflammation in mice microglia line BV-2
by: GU Sheng-long, LI Ming-xing, YING Miao-fa, FANG San-hua, RAO Yue-feng, ZHAO Rui
Published: (2020-02-01)

Bloqueio do receptor de leucotrieno CysLT1 em pacientes com fenômeno de Raynaud: evidência capilaroscópica do papel do leucotrieno CysLT1 receptor inhibition in patients with Raynaud's phenomenon: capillaroscopic evidence of the role of leukotriene
by: Mario Newton Leitão de Azevedo, et al.
Published: (2012-02-01)

Deficiency of astrocyte CysLT1R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission
by: Xiao Liu, et al.
Published: (2022-12-01)

Genetic Variants in COX2 and ALOX Genes and Breast Cancer Risk in White and Black Women
by: Jennifer M. Mongiovi, et al.
Published: (2021-06-01)

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung
by: Lou Saier, et al.
Published: (2022-10-01)

Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease
by: Stefano Fiorucci, et al.
Published: (2022-04-01)

CysLT<sub>2</sub>R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosis Pathway in Gerbils
by: Li Zhou, et al.
Published: (2022-07-01)

Differential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.
by: Wendy Ka-hoi Lau, et al.
Published: (2011-01-01)

Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT<sub>1 </sub>receptor
by: Rekker Erki, et al.
Published: (2008-05-01)

Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors
by: Rute Moreira, et al.
Published: (2020-02-01)

RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R
by: Jana H. Badrani, et al.
Published: (2022-07-01)

Leukotriene D4 induces chemotaxis in human eosinophilc cell line, EoL-1 cells via CysLT1 receptor activation
by: Hideaki Shirasaki, et al.
Published: (2017-11-01)

In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10
by: Ines Da-Costa-Rocha, et al.
Published: (2021-06-01)

CysLT<sub>1 </sub>receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation
by: Capra Valérie, et al.
Published: (2006-03-01)

Leukotriene D4 Stimulates the Migration but Not Proliferation of Endothelial Cells Mediated by the Cysteinyl Leukotriene CysLT1 Receptor via the Extracellular Signal-Regulated Kinase Pathway
by: Yu-Mei Yuan, et al.
Published: (2009-01-01)

Natural product-driven dual COX-LOX inhibitors: Overview of recent studies on the development of novel anti-inflammatory agents
by: Nabarun Mukhopadhyay, et al.
Published: (2023-03-01)

In Vitro and In Silico Investigation of Polyacetylenes from <i>Launaea capitata</i> (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors
by: Fatma M. Abdel Bar, et al.
Published: (2023-04-01)

COX-2 inhibitors /
by: Pairet, M. (Michel), 1959-, et al.
Published: (2004)

Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations[S]
by: Susanna L. Lundström, et al.
Published: (2013-01-01)

Identification and absolute configuration of dihydroxy-arachidonic acids formed by oxygenation of 5S-HETE by native and aspirin-acetylated COX-2
by: Surafel Mulugeta, et al.
Published: (2010-03-01)

Epoxyeicosatrienoic acid (EET)-stimulated angiogenesis is mediated by epoxy hydroxyeicosatrienoic acids (EHETs) formed from COX-2
by: Amy A. Rand, et al.
Published: (2019-12-01)

Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors
by: Viola Noti, et al.
Published: (2023-12-01)

Identification of a Feed-Forward Loop Between 15(S)-HETE and PGE2 in Human Amnion at Parturition
by: Fan Zhang, et al.
Published: (2022-11-01)

Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
by: Muhd Hanis Md Idris, et al.
Published: (2022-09-01)

Interactions of 2-O-arachidonylglycerol ether and ibuprofen with the allosteric and catalytic subunits of human COX-21[S]
by: Liang Dong, et al.
Published: (2016-06-01)

The overexpression of COX 2 in Wilms’ tumor
by: Sara Hashemi
Published: (2014-02-01)

The overexpression of COX 2 in Wilms’ tumor
by: Sara Hashemi
Published: (2014-02-01)

COX-2-dependent and -independent biosynthesis of dihydroxy-arachidonic acids in activated human leukocytes
by: Noemi Tejera, et al.
Published: (2012-01-01)

COX-2 Inhibitors for Cancer Treatment in Dogs
by: Andrigo Barboza De Nardi*, Talita Mariana Morata Raposo1, Rafael Ricardo Huppes1, Carlos Roberto Daleck2 and Renée Laufer Amorim3
Published: (2011-10-01)

Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features
by: Sandhya VENKATACHALA, et al.
Published: (2017-09-01)

Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues
by: Li L, et al.
Published: (2022-08-01)

Deuterated Arachidonic Acids Library for Regulation of Inflammation and Controlled Synthesis of Eicosanoids: An In Vitro Study
by: Dmitry V. Chistyakov, et al.
Published: (2018-12-01)

Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn's disease Avaliação da imunoexpressão de COX-1, COX-2 e p53 na doença de Crohn
by: Mônica Romero, et al.
Published: (2008-12-01)

Dietary ARA Improves COX Activity in Broodstock and Offspring Survival Fitness of a Model Organism (Medaka <i>Oryzias latipes</i>)
by: Agata Kowalska, et al.
Published: (2020-11-01)

Flavonoids: Antiplatelet Effect as Inhibitors of COX-1
by: Cristina Zaragozá, et al.
Published: (2022-02-01)

Inhibition of cyclooxygenase and lipoxygenase activities of momordica charantia /
by: A. Rafidah A. Mohd. Yunos, 1996-, author 625406, et al.
Published: (2019)

Inhibition of cyclooxygenase and lipoxygenase activities of momordica charantia /cA. Rafidah A. Mohd. Yunos
by: A. Rafidah A. Mohd. Yunos, 1996-, author 625406
Published: (2019)